We are live on
!
Find out more
PAM
PVG Asset Management Portfolio holdings
AUM
$173M
1-Year Est. Return
64.51%
This Fund
S&P 500
This Quarter
Est. Return
+5.46%
1 Year Est. Return
+64.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.1M
AUM Growth
-$3.75M
(-15%)
Cap. Flow
-$3.7M
Cap. Flow
% of AUM
-17.49%
Top 10 Holdings %
Top 10 Hldgs %
42.97%
Holding
72
New
28
Increased
7
Reduced
10
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BXMX
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$1.27M |
| 2 |
ProShares Short S&P500
SH
|
+$1.06M |
| 3 |
NVIDIA
NVDA
|
+$856K |
| 4 |
CRDL
Cardiol Therapeutics
CRDL
|
+$822K |
| 5 |
Amazon
AMZN
|
+$693K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$3.73M |
| 2 |
ProShares UltraShort S&P500
SDS
|
+$2.93M |
| 3 |
APA Corp
APA
|
+$757K |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$755K |
| 5 |
Macy's
M
|
+$730K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.35% |
| 2 | Technology | 15.47% |
| 3 | Consumer Discretionary | 4.64% |
| 4 | Real Estate | 4.4% |
| 5 | Consumer Staples | 4.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDL
26
DELISTED
Avadel Pharmaceuticals
AVDL
| $358K | 1.69% |
+34,040
| New | +$413K |
|
27
ExxonMobil
XOM
$644B
| $332K | 1.57% |
+3,089
| New | +$361K |
|
28
Johnson & Johnson
JNJ
$618B
| $331K | 1.56% |
2,286
+61
| +3% | +$9.45K |
|
29
PepsiCo
PEP
$190B
| $317K | 1.5% |
+2,082
| New | +$341K |
|
30
Corning
GLW
$119B
| $309K | 1.46% |
+6,500
| New | +$308K |
|
31
Hershey
HSY
$35.2B
| $288K | 1.36% |
+1,701
| New | +$305K |
|
32
Target
TGT
$65.6B
| $273K | 1.29% |
+2,022
| New | +$290K |
|
33
First Trust Senior Loan Fund ETF
FTSL
$2.32B
| $239K | 1.13% |
+5,170
| New | +$239K |
|
34
AGNC Investment
AGNC
$12.4B
| $238K | 1.13% |
25,860
-11,691
| -31% | -$114K |
|
35
Jack in the Box
JACK
$312M
| $238K | 1.13% |
+5,715
| New | +$264K |
|
|
WBA
36
DELISTED
Walgreens Boots Alliance
WBA
| $228K | 1.08% |
+24,389
| New | +$226K |
|
37
Adobe
ADBE
$99.5B
| $223K | 1.06% |
+502
| New | +$249K |
|
|
SPYM
38
State Street SPDR Portfolio S&P 500 ETF
SPYM
$161B
| $204K | 0.96% |
2,952
-19
| -0.6% | -$1.32K |
|
39
Bank of America
BAC
$435B
| $201K | 0.95% |
+4,580
| New | +$202K |
|
40
Annaly Capital Management
NLY
$17.1B
| $193K | 0.91% |
+10,558
| New | +$206K |
|
41
Arteris
AIP
$1.38B
| $151K | 0.71% |
+14,810
| New | +$122K |
|
|
PIM
42
Franklin Master Intermediate Income Trust
PIM
$150M
| $150K | 0.71% |
+46,087
| New | +$152K |
|
43
BioAtla
BCAB
$5.46M
| $21.3K | 0.1% |
+720
| New | +$60.4K |
|
44
Altimmune
ALT
$552M
| – | – |
-23,668
| Closed | -$145K |
|
45
Advanced Micro Devices
AMD
$776B
| – | – |
-1,307
| Closed | -$215K |
|
|
46
APA Corp
APA
$13.2B
| – | – |
-30,961
| Closed | -$757K |
|
47
Baxter International
BAX
$13.5B
| – | – |
-11,307
| Closed | -$429K |
|
|
BLRX
48
BioLineRX
BLRX
$12.3M
| – | – |
-3,930
| Closed | -$84.3K |
|
49
ProShares Ultra Bloomberg Natural Gas
BOIL
$344M
| – | – |
-1,873
| Closed | -$217K |
|
50
CalciMedica
CALC
$15.8M
| – | – |
-15,115
| Closed | -$67K |
|
Similar funds
IAAG
CTEF
KIM
MC
GRA
VWWMG
RPSM
BAM
PVG Asset Management's Q4 2024 Portfolio in Review
As of Q4 2024, PVG Asset Management held 72 positions worth $21.1M, down 15% from $24.9M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
PVG Asset Management withdrew a net $3.7M in Q4 2024, closing 26 positions and reducing 10 holdings. Its most notable exit was APA Corp, an estimated $757K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, PVG Asset Management opened a new position in Nuveen S&P 500 Buy-Write Income Fund worth $1.28M.
- PVG Asset Management's largest Q4 2024 buy was Nuveen S&P 500 Buy-Write Income Fund: 91,460 shares worth $1.28M.
- PVG Asset Management added most to Anavex Life Sciences in Q4 2024, an estimated $504K increase.
- PVG Asset Management's biggest Q4 2024 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $3.73M.
- PVG Asset Management fully exited APA Corp in Q4 2024, selling an estimated $757K.
- PVG Asset Management's ten largest holdings make up 43% of its $21.1M portfolio in Q4 2024.
- PVG Asset Management opened 28 new positions and closed 26 in Q4 2024.
- PVG Asset Management's portfolio value fell 15% quarter-over-quarter to $21.1M.
Based on PVG Asset Management's 13F filing for Q4 2024, filed 21 Feb 2025.